167 related articles for article (PubMed ID: 24550329)
1. Discovery of compounds blocking the proliferation of Toxoplasma gondii and Plasmodium falciparum in a chemical space based on piperidinyl-benzimidazolone analogs.
Saïdani N; Botté CY; Deligny M; Bonneau AL; Reader J; Lasselin R; Merer G; Niepceron A; Brossier F; Cintrat JC; Rousseau B; Birkholtz LM; Cesbron-Delauw MF; Dubremetz JF; Mercier C; Vial H; Lopez R; Maréchal E
Antimicrob Agents Chemother; 2014 May; 58(5):2586-97. PubMed ID: 24550329
[TBL] [Abstract][Full Text] [Related]
2. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of Toxoplasma gondii and Plasmodium falciparum by nanomolar concentrations of 1-hydroxy-2-dodecyl-4(1H)quinolone, a high-affinity inhibitor of alternative (type II) NADH dehydrogenases.
Saleh A; Friesen J; Baumeister S; Gross U; Bohne W
Antimicrob Agents Chemother; 2007 Apr; 51(4):1217-22. PubMed ID: 17242151
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Mongolian compound library for potential antimalarial and anti-Toxoplasma agents.
Banzragchgarav O; Ariefta NR; Murata T; Myagmarsuren P; Battsetseg B; Battur B; Batkhuu J; Nishikawa Y
Parasitol Int; 2021 Dec; 85():102424. PubMed ID: 34302982
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
Strobl JS; Seibert CW; Li Y; Nagarkatti R; Mitchell SM; Rosypal AC; Rathore D; Lindsay DS
J Parasitol; 2009 Feb; 95(1):215-23. PubMed ID: 18837587
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum.
Baramee A; Coppin A; Mortuaire M; Pelinski L; Tomavo S; Brocard J
Bioorg Med Chem; 2006 Mar; 14(5):1294-302. PubMed ID: 16242338
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
8. Identification of fungal natural products with potent inhibition in
Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
[TBL] [Abstract][Full Text] [Related]
9. Ethanol Extracts from Thai Plants have Anti-Plasmodium and Anti-Toxoplasma Activities In Vitro.
Leesombun A; Boonmasawai S; Nishikawa Y
Acta Parasitol; 2019 Jun; 64(2):257-261. PubMed ID: 30820881
[TBL] [Abstract][Full Text] [Related]
10. Quassinoids exhibit greater selectivity against Plasmodium falciparum than against Entamoeba histolytica, Giardia intestinalis or Toxoplasma gondii in vitro.
Wright CW; Anderson MM; Allen D; Phillipson JD; Kirby GC; Warhurst DC; Chang HR
J Eukaryot Microbiol; 1993; 40(3):244-6. PubMed ID: 8508162
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.
Martin MB; Grimley JS; Lewis JC; Heath HT; Bailey BN; Kendrick H; Yardley V; Caldera A; Lira R; Urbina JA; Moreno SN; Docampo R; Croft SL; Oldfield E
J Med Chem; 2001 Mar; 44(6):909-16. PubMed ID: 11300872
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.
Szajnman SH; Galaka T; Li ZH; Li C; Howell NM; Chao MN; Striepen B; Muralidharan V; Moreno SN; Rodriguez JB
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895021
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 4-Amino 2-Anilinoquinazolines against
Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
[TBL] [Abstract][Full Text] [Related]
14. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
Kortagere S; Mui E; McLeod R; Welsh WJ
J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of wALADin benzimidazoles against different life cycle stages of Plasmodium parasites.
Lentz CS; Sattler JM; Fendler M; Gottwalt S; Halls VS; Strassel S; Arriens S; Hannam JS; Specht S; Famulok M; Mueller AK; Hoerauf A; Pfarr KM
Antimicrob Agents Chemother; 2015 Jan; 59(1):654-8. PubMed ID: 25313210
[TBL] [Abstract][Full Text] [Related]
16. Novel Toxoplasma gondii inhibitor chemotypes.
Sanford AG; Schulze TT; Potluri LP; Hemsley RM; Larson JJ; Judge AK; Zach SJ; Wang X; Charman SA; Vennerstrom JL; Davis PH
Parasitol Int; 2018 Apr; 67(2):107-111. PubMed ID: 29081387
[TBL] [Abstract][Full Text] [Related]
17. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro anti-Toxoplasma gondii activity of a new series of aryloxyacetophenone thiosemicarbazones.
Ansari M; Montazeri M; Daryani A; Farshadfar K; Emami S
Mol Divers; 2020 Nov; 24(4):1223-1234. PubMed ID: 31485890
[TBL] [Abstract][Full Text] [Related]
19. A small-molecule cell-based screen led to the identification of biphenylimidazoazines with highly potent and broad-spectrum anti-apicomplexan activity.
Moine E; Denevault-Sabourin C; Debierre-Grockiego F; Silpa L; Gorgette O; Barale JC; Jacquiet P; Brossier F; Gueiffier A; Dimier-Poisson I; Enguehard-Gueiffier C
Eur J Med Chem; 2015 Jan; 89():386-400. PubMed ID: 25462254
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and potent antiprotozoal activity of mono/di amidino 2-anilinobenzimidazoles versus Plasmodium falciparum and Trypanosoma brucei rhodesiense.
Karaaslan C; Kaiser M; Brun R; Göker H
Bioorg Med Chem; 2016 Sep; 24(18):4038-4044. PubMed ID: 27387356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
